Eicosanoids, Apolipoproteins, Lipoprotein Particles, and Atherosclerosis

Front Matter....Pages i-x
Prostacyclin, EDRF and Atherosclerosis....Pages 1-11
Control of Prostacyclin Production by Vascular Cells : Role of Adenine Nucleotides and Serotonin....Pages 13-20
Prostacyclin and Atherosclerosis -Experimental and Clinical Approaches....Pages 21-29
Platelet-Neutrophil Interactions in the Eicosanoid Pathway....Pages 31-36
Arterial Cell Interactions: Mechanistic Studies Related to Eicosanoid and Growth Factor-Induced Alterations in Cholesterol Metabolism....Pages 37-45
Effects of Plasma Lipoproteins on Eicosanoid Metabolism by Cultured Vascular Smooth Muscle Cells....Pages 47-54
Eicosanoid Synthesis in Platelet-Derived Growth Factor-Stimulated Fibroblasts....Pages 55-59
Genetic HDL Deficiency States....Pages 61-65
Apolipoprotein A-I: Deficiency in Tangier Disease....Pages 67-73
Apolipoprotein C-II Deficiencies: In Vivo Models for Assessing the Significance of Defective Lipolysis on Lipoprotein Metabolism....Pages 75-79
Genetic Variation in the Apolipoproteins C-II and C-III....Pages 81-85
The Effect of Apolipoprotein E Allele Substitutions on Plasma Lipid and Apolipoprotein Levels....Pages 87-93
Molecular Genetics of Coronary Heart Disease....Pages 95-105
Molecular Biology of Human Apolipoprotein B and Related Diseases....Pages 107-121
Secondary and Tertiary Structure of Apolipoproteins....Pages 123-132
Prediction of the Tertiary Structure of Apolipoprotein A-II by Computer Modeling....Pages 133-137
Relationship Between Structure and Metabolism of HDL Apolipoproteins; Study with Synthetic Peptides....Pages 139-147
Heterogeneity in the Conformation of Apo A-I on the Surface of HDL Particles....Pages 149-155
Structural Properties of the Heparin-Binding Domains of Human Apolipoprotein E....Pages 157-163
Characterization and Metabolism of Glycated High Density Lipoproteins in Diabetic Patients....Pages 165-172
Control of Spontaneous Lipid and Protein Transport....Pages 173-177
Modifications in the Chemical Composition and Thermometric Behavior of LDL and HDL by Probucol in Type IIa Hyperlipoproteinemia....Pages 179-184
Serum Amyloid A (SAA) — The Precursor of Protein AA in Secondary Amyloidosis....Pages 185-192
Modulation of Serum Amyloid Gene Expression by Cyotkines and Bacterial Cell Wall Components....Pages 193-201
Protein S and SAA: Genetics, Structure and Metabolism are they Apolipoproteins and Identical....Pages 203-212
Plasma Cholesteryl Ester and Phospholipid Transfer Proteins and their Regulation....Pages 213-217
The Human Plasma Cholesteryl Ester Transfer Protein: Structure, Function and Physiology....Pages 219-224
Cholesterol Ester Transfer Protein, Characterization of Monoclonal Antibodies against the Human Antigen....Pages 225-230
Cholesterol Esterification and Net Mass Transfer of Cholesterylesters and Triglycerides in Plasma From Healthy Subjects and Hyperlipidemic Coronary Heart Disease Patients....Pages 231-237
Lecithin:Cholesterol Acyltransferase and Its Action on Different Substrates....Pages 239-245
In Vivo Evidence for Cholesterol Ester and Triglyceride Exchange between High Density Lipoprotein and Infused Triglyceride Rich Particles in Abetalipoproteinemia....Pages 247-253
Enhanced Cholesteryl Ester Transfer Activity in Cyclophosphamide-Treated Rabbits : Relationship with Lipolytic Enzymes....Pages 255-261
Role of Apolipoprotein A IV in the Interconversion of HDL Subclasses....Pages 263-269
HDL Receptor and Reverse Cholesterol Transport in Adipose Cells....Pages 271-277
Molecular Analysis of Atherogenic Lipoprotein Particles in Adequatelly Controlled Type I Diabetes Mellitus....Pages 279-282
Quantitative Abnormalities of Lipoprotein Particle in Chronic Hemodialysis Patients....Pages 283-287
Lipoprotein Particles in Hypertriglyceridemic States....Pages 289-297
In Vivo Metabolism of Apolipoproteins C-II Aid C-IIII in Normal and Hypertriglyceridemic Subjects....Pages 299-309
Pathogenesis of Hypertriglyceridemia: Implications for Coronary Heart Disease and Therapy....Pages 311-326
Increased VLDL....Pages 327-332
Exchange and Transfer of Apolipoproteins and Lipids: Impact on Lipoprotein Metabolism....Pages 333-338
Hypertriglyceridemia and Omega-3 Fatty Acids....Pages 339-345
Back Matter....Pages 347-362